Utility of the Hemangioma Severity Scale as a Triage Tool and Predictor of Need for Treatment

Jamie L. Mull, Sarah L. Chamlin, Jin Shei Lai, Jennifer L. Beaumont, David Cella, Elizabeth A. Rancour, Eulalia Baselga, Anita Haggstrom

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Background/Objectives: Infantile hemangiomas (IHs) are commonly encountered in primary care and most often remain asymptomatic, resolving without sequelae. Certain characteristics are associated with a greater risk of complications, associated anomalies, and disfigurement. The heterogeneous presentation poses a clinical challenge for physicians in determining the need for treatment and subspecialty referral. This study aims to evaluate the utility of the previously published Hemangioma Severity Scale (HSS) to predict the need for treatment. Methods: This retrospective study included 106 patients with IHs seen in the Indiana University Dermatology Clinic in 2011. Data from electronic medical records and clinical photographs taken at patients' initial visits were used to score the hemangiomas using the HSS. Treatments used over 9 to 14 months of follow-up were recorded. Results: Four HSS score subgroups were identified. Higher HSS scores correlated with the need for treatment; 98% of patients with HSS scores of 10 or greater received local or systemic therapy. Higher HSS scores also correlated with greater frequency of complications and risks of associated structural anomalies and permanent disfigurement. Scores did not correlate with sex, age at initial presentation, history of bleeding or pain, or IH size. Conclusions: The HSS may be a useful tool for primary care physicians in identifying high-risk IHs that may benefit from therapy. This easy-to-use scale can improve clinical outcomes by identifying which patients need intervention to minimize complications. IHs with total HSS scores of 6 or greater should be referred for subspecialty evaluation.

Original languageEnglish (US)
Pages (from-to)78-83
Number of pages6
JournalPediatric Dermatology
Volume34
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Triage
Hemangioma
Therapeutics
Electronic Health Records
Primary Care Physicians
Dermatology
Primary Health Care

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Dermatology

Cite this

Utility of the Hemangioma Severity Scale as a Triage Tool and Predictor of Need for Treatment. / Mull, Jamie L.; Chamlin, Sarah L.; Lai, Jin Shei; Beaumont, Jennifer L.; Cella, David; Rancour, Elizabeth A.; Baselga, Eulalia; Haggstrom, Anita.

In: Pediatric Dermatology, Vol. 34, No. 1, 01.01.2017, p. 78-83.

Research output: Contribution to journalArticle

Mull, JL, Chamlin, SL, Lai, JS, Beaumont, JL, Cella, D, Rancour, EA, Baselga, E & Haggstrom, A 2017, 'Utility of the Hemangioma Severity Scale as a Triage Tool and Predictor of Need for Treatment', Pediatric Dermatology, vol. 34, no. 1, pp. 78-83. https://doi.org/10.1111/pde.13032
Mull, Jamie L. ; Chamlin, Sarah L. ; Lai, Jin Shei ; Beaumont, Jennifer L. ; Cella, David ; Rancour, Elizabeth A. ; Baselga, Eulalia ; Haggstrom, Anita. / Utility of the Hemangioma Severity Scale as a Triage Tool and Predictor of Need for Treatment. In: Pediatric Dermatology. 2017 ; Vol. 34, No. 1. pp. 78-83.
@article{22a091f489d14913b6399cc91e4e8df3,
title = "Utility of the Hemangioma Severity Scale as a Triage Tool and Predictor of Need for Treatment",
abstract = "Background/Objectives: Infantile hemangiomas (IHs) are commonly encountered in primary care and most often remain asymptomatic, resolving without sequelae. Certain characteristics are associated with a greater risk of complications, associated anomalies, and disfigurement. The heterogeneous presentation poses a clinical challenge for physicians in determining the need for treatment and subspecialty referral. This study aims to evaluate the utility of the previously published Hemangioma Severity Scale (HSS) to predict the need for treatment. Methods: This retrospective study included 106 patients with IHs seen in the Indiana University Dermatology Clinic in 2011. Data from electronic medical records and clinical photographs taken at patients' initial visits were used to score the hemangiomas using the HSS. Treatments used over 9 to 14 months of follow-up were recorded. Results: Four HSS score subgroups were identified. Higher HSS scores correlated with the need for treatment; 98{\%} of patients with HSS scores of 10 or greater received local or systemic therapy. Higher HSS scores also correlated with greater frequency of complications and risks of associated structural anomalies and permanent disfigurement. Scores did not correlate with sex, age at initial presentation, history of bleeding or pain, or IH size. Conclusions: The HSS may be a useful tool for primary care physicians in identifying high-risk IHs that may benefit from therapy. This easy-to-use scale can improve clinical outcomes by identifying which patients need intervention to minimize complications. IHs with total HSS scores of 6 or greater should be referred for subspecialty evaluation.",
author = "Mull, {Jamie L.} and Chamlin, {Sarah L.} and Lai, {Jin Shei} and Beaumont, {Jennifer L.} and David Cella and Rancour, {Elizabeth A.} and Eulalia Baselga and Anita Haggstrom",
year = "2017",
month = "1",
day = "1",
doi = "10.1111/pde.13032",
language = "English (US)",
volume = "34",
pages = "78--83",
journal = "Pediatric Dermatology",
issn = "0736-8046",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Utility of the Hemangioma Severity Scale as a Triage Tool and Predictor of Need for Treatment

AU - Mull, Jamie L.

AU - Chamlin, Sarah L.

AU - Lai, Jin Shei

AU - Beaumont, Jennifer L.

AU - Cella, David

AU - Rancour, Elizabeth A.

AU - Baselga, Eulalia

AU - Haggstrom, Anita

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Background/Objectives: Infantile hemangiomas (IHs) are commonly encountered in primary care and most often remain asymptomatic, resolving without sequelae. Certain characteristics are associated with a greater risk of complications, associated anomalies, and disfigurement. The heterogeneous presentation poses a clinical challenge for physicians in determining the need for treatment and subspecialty referral. This study aims to evaluate the utility of the previously published Hemangioma Severity Scale (HSS) to predict the need for treatment. Methods: This retrospective study included 106 patients with IHs seen in the Indiana University Dermatology Clinic in 2011. Data from electronic medical records and clinical photographs taken at patients' initial visits were used to score the hemangiomas using the HSS. Treatments used over 9 to 14 months of follow-up were recorded. Results: Four HSS score subgroups were identified. Higher HSS scores correlated with the need for treatment; 98% of patients with HSS scores of 10 or greater received local or systemic therapy. Higher HSS scores also correlated with greater frequency of complications and risks of associated structural anomalies and permanent disfigurement. Scores did not correlate with sex, age at initial presentation, history of bleeding or pain, or IH size. Conclusions: The HSS may be a useful tool for primary care physicians in identifying high-risk IHs that may benefit from therapy. This easy-to-use scale can improve clinical outcomes by identifying which patients need intervention to minimize complications. IHs with total HSS scores of 6 or greater should be referred for subspecialty evaluation.

AB - Background/Objectives: Infantile hemangiomas (IHs) are commonly encountered in primary care and most often remain asymptomatic, resolving without sequelae. Certain characteristics are associated with a greater risk of complications, associated anomalies, and disfigurement. The heterogeneous presentation poses a clinical challenge for physicians in determining the need for treatment and subspecialty referral. This study aims to evaluate the utility of the previously published Hemangioma Severity Scale (HSS) to predict the need for treatment. Methods: This retrospective study included 106 patients with IHs seen in the Indiana University Dermatology Clinic in 2011. Data from electronic medical records and clinical photographs taken at patients' initial visits were used to score the hemangiomas using the HSS. Treatments used over 9 to 14 months of follow-up were recorded. Results: Four HSS score subgroups were identified. Higher HSS scores correlated with the need for treatment; 98% of patients with HSS scores of 10 or greater received local or systemic therapy. Higher HSS scores also correlated with greater frequency of complications and risks of associated structural anomalies and permanent disfigurement. Scores did not correlate with sex, age at initial presentation, history of bleeding or pain, or IH size. Conclusions: The HSS may be a useful tool for primary care physicians in identifying high-risk IHs that may benefit from therapy. This easy-to-use scale can improve clinical outcomes by identifying which patients need intervention to minimize complications. IHs with total HSS scores of 6 or greater should be referred for subspecialty evaluation.

UR - http://www.scopus.com/inward/record.url?scp=85007291555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007291555&partnerID=8YFLogxK

U2 - 10.1111/pde.13032

DO - 10.1111/pde.13032

M3 - Article

VL - 34

SP - 78

EP - 83

JO - Pediatric Dermatology

JF - Pediatric Dermatology

SN - 0736-8046

IS - 1

ER -